全球DNA定序市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球DNA定序市場預計將從2025年的193億美元成長至2034年的1,173.4億美元，並預計在2026年至2034年間以22.21%的複合年成長率成長。基因組研究和生物技術的進步推動了全球DNA定序市場的顯著成長。 DNADNA測序技術使科學家能夠識別遺傳物質中核苷酸的精確序列，從而更深入地了解生物過程和疾病。這些技術廣泛應用於醫學研究、藥物研發、農業和個人化醫療等領域。

DNA定序市場的主要促進因素包括基因組研究的活性化和精準醫療需求的成長。醫療專業人員和研究人員正在利用定序技術來識別基因突變並開發標靶療法。此外，定序成本的降低和資料分析工具的改進也使得這些技術更容易被實驗室和研究機構所採用。

隨著基因組醫學的不斷發展，DNA定序市場的未來前景依然十分光明。定序速度、準確性和成本效益的提升有望擴大其在臨床診斷和醫療應用中的用途。生物技術和生命科學研究投入的增加預計將進一步加速創新和市場成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：我們全面檢驗主要地理區域的市場表現，識別高成長領域和區域趨勢，並深入了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球DNA定序市場：依產品及服務分類

• 市場分析、洞察與預測
• 消耗品
• 裝置
• 服務

第5章 全球DNA定序市場：依技術分類

• 市場分析、洞察與預測
• 桑格定序
• 次世代定序（全基因測序(WGS)、全EXOME定序(WES)、標靶定序與定序）
• 第三代DNA定序（單分子即時定序（SMRT）、奈米孔定序）

第6章 全球DNA定序市場：依工作流程分類

• 市場分析、洞察與預測
• 定序預處理
• 定序
• 數據分析

第7章 全球DNA定序市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 生殖健康
• 臨床研究
• 農業基因組學與法醫學
• HLA型檢測/免疫系統監測
• 總體基因體學、流行病學和藥物研發
• 消費者基因體學
• 其他

第8章 全球DNA定序市場：依最終用途分類

• 市場分析、洞察與預測
• 學術研究
• 臨床研究
• 醫院和診所
• 製藥和生物技術公司
• 其他用戶

第9章 全球DNA定序市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • IlluminaInc
  • Thermo Fisher Scientific Inc
  • Agilent TechnologiesInc
  • QIAGEN NV
  • F. Hoffmann-La Roche Ltd
  • Pacific Biosciences Of California, Inc.（PacBio）
  • Oxford Nanopore Technologies Plc
  • BGI Genomics Co.Ltd
  • Bio-Rad LaboratoriesInc
  • MacrogenInc
  • Novogene Co.Ltd
  • MGI Tech Co.Ltd
  • Twist Bioscience Corporation
  • GENEWIZ, Inc.（Azenta Life Sciences）
  • GenScript Biotech Corporation
  • Element BiosciencesInc
  • Ultima GenomicsInc

The global DNA sequencing market size is expected to reach USD 117.34 Billion in 2034 from USD 19.30 Billion in 2025, growing at a CAGR of 22.21% during 2026-2034.The global DNA sequencing market has experienced significant growth due to advancements in genomic research and biotechnology. DNA sequencing technologies allow scientists to determine the precise order of nucleotides in genetic material, enabling deeper understanding of biological processes and diseases. These technologies are widely used in medical research, drug discovery, agriculture, and personalized medicine.

Key drivers of the DNA sequencing market include increasing research in genomics and rising demand for precision medicine. Healthcare providers and researchers use sequencing technologies to identify genetic mutations and develop targeted treatments. Declining sequencing costs and improvements in data analysis tools have also made these technologies more accessible to laboratories and research institutions.

The future prospects of the DNA sequencing market remain highly promising as genomic medicine continues to evolve. Advances in sequencing speed, accuracy, and affordability may expand its use in clinical diagnostics and healthcare. Growing investments in biotechnology and life sciences research are expected to further accelerate innovation and market growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Services

• Consumables
• Instruments
• Services

By Technology

• Sanger Sequencing
• Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing)
• Third Generation DNA Sequencing (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing)

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Application

• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Consumer Genomics
• Others

By End-use

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other Users

COMPANIES PROFILED

• Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc. (PacBio), Oxford Nanopore Technologies plc, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Macrogen, Inc., Novogene Co., Ltd., MGI Tech Co., Ltd., Twist Bioscience Corporation, GENEWIZ, Inc. (Azenta Life Sciences), GenScript Biotech Corporation, Element Biosciences, Inc., Ultima Genomics, Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SEQUENCING MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Next-Generation Sequencing (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing & Resequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Third Generation DNA Sequencing (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Reproductive Health Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinical Investigation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Agrigenomics & Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. HLA Typing/Immune System Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Metagenomics, Epidemiology & Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Consumer Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Other Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL DNA SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technology
  • 9.2.3 By Workflow
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technology
  • 9.3.3 By Workflow
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Spain
  • 9.3.11 Russia
  • 9.3.12 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technology
  • 9.4.3 By Workflow
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 China
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 India
  • 9.4.10 Australia
  • 9.4.11 South East Asia
  • 9.4.12 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technology
  • 9.5.3 By Workflow
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technology
  • 9.6.3 By Workflow
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL DNA SEQUENCING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 IlluminaInc
  • 11.2.2 Thermo Fisher Scientific Inc
  • 11.2.3 Agilent TechnologiesInc
  • 11.2.4 QIAGEN N.V
  • 11.2.5 F. Hoffmann-La Roche Ltd
  • 11.2.6 Pacific Biosciences Of California, Inc. (PacBio)
  • 11.2.7 Oxford Nanopore Technologies Plc
  • 11.2.8 BGI Genomics Co.Ltd
  • 11.2.9 Bio-Rad LaboratoriesInc
  • 11.2.10 MacrogenInc
  • 11.2.11 Novogene Co.Ltd
  • 11.2.12 MGI Tech Co.Ltd
  • 11.2.13 Twist Bioscience Corporation
  • 11.2.14 GENEWIZ, Inc. (Azenta Life Sciences)
  • 11.2.15 GenScript Biotech Corporation
  • 11.2.16 Element BiosciencesInc
  • 11.2.17 Ultima GenomicsInc